Given Imaging Ltd. (GIVN) Wednesday reported positive data from the European multicenter study of PillCam COLON 2 confirming that the second-generation PillCam COLON capsule has higher sensitivity for colorectal polyp detection than the first generation technology.
Colon capsule endoscopy is a non-invasive, painless technology that can visualize the colon without sedation or air insufflation, potentially making it an excellent tool for encouraging broader compliance with colorectal cancer screening guidelines.
The study was conducted at eight European sites compared colon capsule endoscopy with conventional colonoscopy for the detection of colorectal polyps or masses greater than or equal to 6 mm in size in a cohort of patients at average or increased risk of colorectal neoplasia.
The goal of the study was to determine the feasibility, accuracy and safety of the upgraded PillCam COLON capsule by comparing it directly with colonoscopy. Per-patient colon capsule endoscopy sensitivity for polyps 6 mm and over and those 10 mm and over was 84 percent and 88 percent, with specificities of 64 percent and 95 percent, respectively.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.